-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Vaxcyte, Raises Price Target to $89

Benzinga·02/26/2026 11:20:24
Listen to the news
BTIG analyst Thomas Shrader maintains Vaxcyte (NASDAQ:PCVX) with a Buy and raises the price target from $85 to $89.